RxDoctor Payments Data

Jarrod Eastep, PA

Physician Assistant · Parma, OHNPI 1144642547

Payments from drug & device makers

$2,845in general payments, 2019–2025

Across 184 payments — averaging $15.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$554
  • Novartis$546
  • Amgen$359
  • E.r. Squibb & Sons, L.L.C.$340
  • AstraZeneca$257
  • Merck$166
  • plus $623 from 14 others

What the payments were for

  • Food & beverage$2,845100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,845 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$56,163
Medicare patients
390
Services billed
639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban357$335,013
EntrestoSacubitril/Valsartan84$92,369
Repatha SureclickEvolocumab73$86,987
XareltoRivaroxaban53$80,140
JardianceEmpagliflozin16$27,188
BrilintaTicagrelor25$19,008
Praluent PenAlirocumab11$14,287
FarxigaDapagliflozin Propanediol13$12,845
VerquvoVericiguat17$11,221
MultaqDronedarone Hcl13$10,659
Ranolazine ErRanolazine40$5,734
Metoprolol Succinate322$3,999
Dofetilide11$3,350
Atorvastatin Calcium332$2,991
Rosuvastatin Calcium149$2,814

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$142$335,013357 claims
NovartisEntresto$546$92,36984 claims
Johnson & JohnsonXarelto$554$80,14053 claims
AstraZenecaBrilinta, Farxiga$257$31,85338 claims
Boehringer IngelheimJardiance$17$27,18816 claims
MerckVerquvo$166$11,22117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Parma

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →